VRTX
Vertex Pharmaceuticals Inc
505.60$
+0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.4% | +6.7% | -1.5% | +4.8% | +5.1% | -4.9% | +7.0% | +3.8% | +4.9% | -7.4% | +11.6% | – | |
| – | +15.5% | -6.9% | +8.6% | +5.6% | +7.8% | -14.3% | +12.3% | +1.8% | +12.3% | -15.7% | +24.5% | – | |
| – | -0.7% | +9.1% | -3.0% | +4.6% | +4.6% | -3.3% | +6.2% | +4.1% | +3.7% | -6.0% | +9.7% | – | |
| – | +56.9% | -35.9% | +525.4% | -83.8% | +14.0% | -1.9% | -0.1% | +5.5% | -5.7% | -1.2% | +3.3% | – | |
| – | +39.9% | -7.2% | +8.6% | -0.1% | +1.6% | +5.0% | +7.1% | +4.8% | +9.4% | +1.4% | +17.9% | – | |
| – | +3.2% | +4.1% | +379.0% | -78.2% | +15.8% | +21.5% | -20.9% | +4.9% | -1.0% | -0.3% | +9.7% | – | |
| – | -4.8% | +15.3% | -408.4% | – | -8.1% | -38.6% | +82.7% | +3.0% | +9.6% | -12.5% | +9.6% | – | |
| – | -2.8% | -1.9% | -4.8% | -24.2% | -62.7% | +7.1% | +23.3% | -10.8% | +0.0% | – | – | – | |
| – | -2.7% | +11.5% | -365.1% | – | -7.2% | -35.7% | +75.7% | +1.2% | +2.5% | -5.9% | +11.1% | – | |
| – | +24.3% | +0.4% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% | +58.3% | +31.8% | – | |
| – | -6.4% | +13.5% | -426.8% | – | -12.7% | -29.2% | +59.8% | +4.8% | +10.0% | -13.4% | +6.6% | – | |
| – | -1.2% | +10.3% | -347.8% | – | -7.8% | -34.0% | +71.2% | +1.3% | +2.3% | -5.7% | +6.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.